Posters & Publications :: ProMIS Neurosciences, Inc. (PMN)

Years of Research at Your Fingertips

ProMIS Neurosciences’ publications and posters provide ample background on our research surrounding neurodegenerative diseases.

Discovery

AAN 2022 Poster - RACK1 Knockdown Alleviates TDP-43 Associated Global Translational Suppression in vitro, and Neurodegeneration in vivo

PMN310 | Amyloid-Beta

NDD 2022 Presentation - Selective Antibody Targeting of Pathogenic Proteins: maximizing target engagement, minimizing target distraction

PMN311 | AD Vaccine

AD/PD 2022 Presentation - Optimizing vaccine design for Alzheimer’s disease: Selective targeting of computationally-derived conformational B cell epitopes of soluble amyloid-beta toxic oligomers

PMN267 | TDP-43

AAIC 2021 Presentation - Selective Targeting of Intracellular Misfolded, Pathogenic TDP-43 with Rationally Designed Intrabodies

EpiSelect™ Platform

AAIC 2021 Poster - Conformational epitopes exposed on misfolded toxic forms of amyloid-beta, tau and alpha-synuclein directly contribute to their seeding activity

PMN442 | Alpha-Synuclein

AAN 2020 Presentation - Achieving an optimal profile for immunotherapy of alpha-synucleinopathies: Rational generation of monoclonal antibodies selective for pathogenic forms of alpha-synuclein

PMN267 | TDP-43

AAN 2020 Presentation - Generation of antibodies selective for misfolded disease-associated TDP-43

Discovery

AAIC 2020 Presentation - Rationally designed antibodies selective for pathogenic tau aggregates

PMN267 | TDP-43

AAIC 2020 Poster - Targeting of misfolded, pathogenic TDP-43 with rationally designed antibodies

PMN310 | Amyloid-Beta

AAIC 2020 Poster - Epitope prediction for oligomer-selective antibodies in tau and Aβ